Get Beam Therapeutics, Inc.'s stock price today. BEAM: Get the latest Beam Therapeutics stock price and detailed information including BEAM news, historical charts and realtime prices. View Beam Suntory stock / share price, financials, funding rounds, investors and more at Craft. All rights reserved. Company profile page for Beam Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information In 2014 it bought Beam Inc. whose brands include Jim Beam and Maker's Mark, Canadian Club and Courvoisier. ARN keeps track of all major brokerages’ stock ratings and recommendations, including Goldman This price target is based on 6 analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. Beam Therapeutics' physical mailing address is 26 LANDSDOWNE STREET, CAMBRIDGE MA, 02139. The cost may differ from place to place. It has a research and clinical collaboration agreement with Magenta Therapeutics, Inc. Beam Therapeutics Inc. was founded in 2017 and is based in Cambridge, Massachusetts. Suntory is a Japanese business group best known for its whisky range, though its other interests include soft drinks, beer, wine and health foods. In 2014 it bought Beam Inc. whose brands include Jim Beam and Maker's Mark, Canadian Club and Courvoisier. Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. Beam Therapeutics started at outperform with $32 stock price target at Wedbush Mar. beam $97.06 $2.98 3.2% Price as of January 12, 2021, 9:00 p.m. EST View Interactive BEAM Charts In 2013 Suntory Holdings Limited made close to $4 billion when it debuted on the Tokyo Stock Exchange. Beam Suntory. Find the latest Beam Therapeutics Inc. (BEAM) stock quote, history, news and other vital information to help you with your stock trading and investing. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BEAM will outperform the market and that investors should add to their positions of Beam Therapeutics. In 2014 it bought Beam Inc. whose brands include Jim Beam and Maker's Mark, Canadian Club and Courvoisier. Beam Suntory has raised $5.17 m in total funding. The JIM BEAM brand, founded in 1795 (United States), has more than 96 sister brands and more than 1 027 competing brands. Beam Inc. historical price data and BEAM charts. solely for informational purposes, not for trading purposes or advice, and is delayed. With a performance objective of being the world’s most admired and fastest growing premium spirits company, and a vision of Growing for Good, we're driving growth through quality craftsmanship, consumer connections and entrepreneurial spirit. Fundamental Beam Suntory is the third largest producer of distilled spirits in the world behind Diageo and Pernod Ricard. Trading volume was a total of 398.30K shares. Beam is the fourth largest premium spirits company in the world and the largest U.S.-based spirits company, with 10 of the world's top-100 premium spirits in our portfolio and $2.7 billion in annual revenue. Suntory also acquired the soft drink company Orangina and energy drink company Frucor in 2009. © 2021 Verizon Media. Analyst Ratings Network (ARN) provides comprehensive coverage of stock ratings, including equities research analysts’ upgrades, downgrades, new coverage and price target View BEAM's dividend history, dividend yield, date and payout ratio at MarketBeat. In 2011, after two-plus centuries of craftsmanship and growth, Beam has become a stand-alone publicly traded company (NYSE: BEAM). Wedbush has the highest price target set, predicting BEAM will reach $40.00 in the next twelve months. changes. Payout Estimate. Looking back at BEAM historical stock prices for the last five trading days, on November 23, 2020, BEAM opened at $42.15, traded as high as $42.90 and as low as $41.38, and closed at $42.47. Market Data is delayed by 15 minutes and is for informational and/or educational purposes only. Beam Inc. (BEAM) stock price, charts, trades & the US's most popular discussion forums. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Suntory Targets Net Zero Greenhouse Gas Emissions Across Entire Value Chain - Company Raises Ambition of its 2050 … Subscribe to Premium to view Fair Value for BEAM. The acquisition was completed in April 2014, for a final cost of about $16 billion, when it was announced that Beam would become a subsidiary named "Beam Suntory." Currency in USD, Trade prices are not sourced from all markets, Quiet Bull Market Erupting in This Tiny Sector. MARKETS. beam $97.06 $2.98 3.2% Price as of January 12, 2021, 9:00 p.m. EST View Interactive BEAM Charts The slopes of the 50-day and 200-day moving averages are positive, but these are lagging indicators. In this daily Japanese candlestick chart of BEAM, below, we can see a limited base around the $20 area followed by three plus months of soaring prices. Beam Suntory brands have been bringing people together for more than 200 years. View today's stock price, news and analysis for Suntory Beverage & Food Ltd. (2587). Mar 31, 2014 11:40 AM EDT. The key questions answered in this report: What will be the Market Size and Growth Rate in the forecast year? Looking back at BEAM historical stock prices for the last five trading days, on November 23, 2020, BEAM opened at $42.15, traded as high as $42.90 and as low as $41.38, and closed at $42.47. BEAM: Get the latest Beam Therapeutics stock price and detailed information including BEAM news, historical charts and realtime prices. In 2014 Suntory had acquired Beam Inc changing the company name to 'Beam Suntory'. Beam Suntory has raised $5.17 m in total funding. more. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. The company's listed phone number is 857-327-8775 and its investor relations email address is investors@beamtx.com. The JIM BEAM brand is owned by Suntory Beverage & Food , a company listed in Frankfurt. Free forex prices, toplists, indices and lots more. Massive paydays could be on the way for those who know about California's Bay Area "Green Ring". Trading … You can consume it like a shot as well. The Jim Beam Prices 750ml will be around $26.99. Information is provided ‘as-is’ and S&P 500 3,735.36 (+0.87%) Since the beginning of its partnership with Beam Suntory in 2013, Stock Polska has more than doubled the market share of its Beam Suntory brands from 2.5% to 6.5% (MAT). Stock markets’ extreme valuation gaps divide veteran investors; ... which hit the market at a price of £100, shot up to £3,500 online. sell any security. Pernod Ricard, Kahlua, Beam Suntory, Distell, De Kuyper, Gruppo Campari, Rémy Cointreau, Kwai Feh, Passoa, Thorntons, Stock Spirits Group, Diageo. BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% BEAM: NYSE (Stock) Beam Inc. Dividend policy None Price as of: NOV 23, 11:00 AM EDT $42.47 +0.84 +2.02% Watchlist Overview. Learn about STBFY (PINX) with our data and independent analysis including price, star rating, valuation, dividends, and financials. The ISIN, the company's International Securities Identification Number, is JP3336560002. Suntory also acquired the soft drink company Orangina and energy drink company Frucor in 2009. ... Beam soars on Suntory buyout for $83.50 per share Jan. 13, 2014 at 1:13 p.m. The current consensus among 6 investment analysts is to buy stock in Beam Therapeutics. The company is exploring a technology called base editing to potentially develop a new class of precision genetic medicines, according to its website. The average price target is $32.00, with a high forecast of $33.00 and a low forecast of $31.00. Suntory Group is a global leader in consumer packaged goods, producing and distributing a uniquely diverse portfolio of beverages, premium spirits, beer and wine, and wellness products throughout the world. Looking back at BEAM historical stock prices for the last five trading days, on December 24, 2020, BEAM opened at $91.00, traded as high as $91.57 and as low as $85.82, and closed at $87.84. Stock Spirits è Il Nuovo Distributore Per Beam Suntory In Italia Thespot News. Suntory is a Japanese business group best known for its whisky range, though its other interests include soft drinks, beer, wine and health foods. View Beam Suntory stock / share price, financials, funding rounds, investors and more at Craft. In January 2014, Suntory announced a deal to buy Beam Inc. for about $13.6 billion. Single Malt Whiskey Market Professional Study In-depth Analysis 2020 to 2026 | Bacardi, Beam Suntory, Brown-Forman, Diageo www.marketwatch.com - April 7 at 5:13 PM: Global Alcoholic Beverages Market Gain A Stronghold by 2029| Bacardi Limited, Beam Suntory Inc. and Anheuser-Busch InBev SA/NV www.marketwatch.com - March 27 at 12:45 PM Promoting price improvement for individual investors on retail order flow for NYSE listed securities. 22/12/2020 13:23:14 1-888-992-3836 Free Membership Login Hybrid bonds and subordinated loans. Investor Relations (Management Policy, Earnings Releases, Financial Data,IR Library,Stock Information) for Suntory Beverage & Food Limited (SBF) Get New Beam Therapeutics Analyst Ratings Delivered To Your Inbox. Beam Suntory Launches Exclusive Whisky For Indian Market The Economic Times . Beam Therapeutics (BEAM) has the following price history information. The deal should be finalized in the second quarter of 2014. Today's Strong And Under The Radar Stock: Beam (BEAM) By Jamie Hodge. EV stocks have soared 500%, 800%, even 1,000% this year. 25, 2019 at 4:21 p.m. ET by Associated Press This $100 Tyrconnell is another sign … That price was a 25% premium over Beam's closing price on Friday. Suntory Launches New Joint Venture Company to Develop Innovative Anellotech Plas-TCat Plastics Recycling Technology. Stock analysis for Beam Therapeutics Inc (BEAM:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Indeed, at the acquisition price of $83.50 per share, total shareholder return will stand at 106% since Beam began trading as a standalone spirits company in October of 2011. Jim Beam parent Suntory spending tens of millions to make more craft whiskeys Jul. Beam Therapeutics currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The following Wall Street sell-side analysts have issued research reports on Beam Therapeutics in the last year: Barclays PLC, Jefferies Financial Group Inc., JPMorgan Chase & Co., Stifel Nicolaus, Wedbush, William Blair, and Zacks Investment Research. Real Time Data. Suntory has supplemented its organic growth in overseas markets with strategic acquisitions including New Zealand beverage company Frucor Group and French beverage company Orangina Schweppes Group in 2009 … Traded Products. VIew our Data Insights Blog. You can check the Jim Beam Bottle Value and price on the official website of Jim Beam or any other website, but its most authentic price is provided here. NYSE Equities, Options, ETFs & Bonds. Stock Spirits Reports Strong First Quarter. Move your mouse over past months for details. Date of issue: Name of Subordinated loans: Currency: Amount (Millions of Yen) Outstanding Balance (Millions of Yen) Trading volume was a total of 308.50K shares. BEAM stock quote, chart and news. Suntory said on Monday that it would pay $83.50 per share in cash, a 25 percent premium to Beam’s closing stock price of $66.97 on Friday. Stocks of start-ups wielding tools like Crispr-Cas9 that allow companies to edit DNA and attack genetic diseases and cancer are suddenly hot. Low-latency, real-time market data feeds cover the various asset classes and markets in the NYSE Group . ET by Tomi Kilgore Beam Therapeutics to offer 6.25 million shares in … ARN does not provide financial advice and does not issue recommendations or offers to buy stock or In 2013 Suntory Holdings Limited made close to $4 billion when it debuted on the Tokyo Stock Exchange. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Beam Suntory Launches Two New Scotch Brands In India The Economic Times. But the science is moving with incredible speed and the competition is rising. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. In 2014 Suntory bought Americas largest bourbon producer Beam Inc. for $16 Billion and Beam Inc. was renamed to Beam-Suntory. Beam Therapeutics (BEAM) has the following price history information. The average price target represents a -69.69% upside from the last price of $110.84. As a world leader in premium spirits, Beam Suntory is inspiring human connections. We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Data. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that determination. All rights reserved. Trading volume was a total of 308.50K shares. © American Consumer News, LLC dba Analyst Ratings Network ® 2010-2021. Trading volume was a total of 398.30K shares. Suntory Pledges ￥50 million to support the Relief and Recovery of the Kumamoto area affected by the heavy rain. The average price target is $33.60, with a high forecast of $40.00 and a low forecast of $31.00. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $31.00 for Beam Therapeutics in the next year. Eat Beyond is a rising new star in the alternative meat space and is the very first to provide retail investors with the opportunity to participate in one of the fastest growing industries around! About Us Beam Suntory India: The brand aims to reach $1 billion in sales in India by 2030. Quote. Craft Spirits Market 2020-2024- Featuring Bacardi Ltd., Beam Suntory Inc., Black Button Distilling, Among Others | Industry Analysis, Market Trends, Market Growth, Opportunities and … August 6, 2020. Suntory Beverage & Food Limited ADR (STBFY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). June 30, 2020. New. Payout History. Free real-time prices, trades, and chat. Historical Market Data. Note: Quote Data is Delayed At Least 15 Minutes. The Next Big Thing in Plant-based Foods is This Company. Beam Therapeutics (BEAM) has the following price history information. Sign-up to receive the latest news and ratings for BEAM and its competitors with Analyst To see all Proprietary Market Data Solutions. Ratings Network’s free daily newsletter. The company was founded by David R. Liu, Feng Zhang and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA. Is Beam Therapeutics (NYSE:BEAM) a good stock for dividend investors? Beam Therapeutics (BEAM) has the following price history information. 326 E 8th St #105, Sioux Falls, SD 57103. We are Beam Suntory. Suntory is a Japanese business group best known for its whisky range, though its other interests include soft drinks, beer, wine and health foods. Suntory Group is committed to our founding promise to coexist with people and nature. Our world-renowned bourbons, Japanese whiskies, single malt scotches, tequilas and cognac are perfect for any occasion, whether it's a celebration in Kentucky, after-work drink in Tokyo, or a reunion in Madrid. Compare. Since then, BEAM stock has increased by 342.7% and is now trading at $94.08. The ISIN, the company's International Securities Identification Number, is JP3336560002. Beam Suntory carefully crafts your favorites and new classics ready to be explored. James Beam began his career in 1795 selling barrels of whiskey and by 1935 the family had established the James B. Beam distilling company. exchange delays and terms of use please see disclaimer. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Sachs, JPMorgan Chase, Wells Fargo, Bank of America/Merrill Lynch, Citigroup, Morgan Stanley and many In 2014 Suntory bought Americas largest bourbon producer Beam Inc. for $16 Billion and Beam Inc. was renamed to Beam-Suntory. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. The JIM BEAM brand is owned by Suntory Beverage & Food , a company listed in Frankfurt. ※Suntory Group has adopted IFRS 16 "Leases" since FY2019 *1 Equity credit for Hybrid bonds and subordinated loans. Other Information. The average price target represents a 29.45% upside from the last price of $24.72. Learn about STBFY (PINX) with our data and independent analysis including price, star rating, valuation, dividends, and financials. James Beam began his career in 1795 selling barrels of whiskey and by 1935 the family had established the James B. Beam distilling company. The JIM BEAM brand, founded in 1795 (United States), has more than 96 sister brands and more than 1 027 competing brands. Beam Suntory is the third largest producer of distilled spirits in the world behind Diageo and Pernod Ricard. Suntory Buys Beam for $16 Billion, Gets Maker's Mark and Jim Beam. Looking back at BEAM historical stock prices for the last five trading days, on December 24, 2020, BEAM opened at $91.00, traded as high as $91.57 and as low as $85.82, and closed at $87.84. Beam Therapeutics' stock was trading at $21.25 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Beam Inc. (BEAM) stock price, charts, trades & the US's most popular discussion forums. View real-time stock prices and stock quotes for a full financial overview. Suntory will acquire Deerfield, Ill.-based Beam in a deal valued at $16 billion, or $83.50 a share, 25 percent above the stock's closing price Friday, the companies said in a joint news release. Beam Suntory And Stock Spirits Group Expand Polish Distribution Ties Beverage Industry News Just Drinks. Matt Shattock comes from Chicago-based spirits group Beam Suntory Search FT.com for Suntory Beverage & Food Ltd 2587:TYO price moved over +1.10% to 3,690.00 Jan 04 2021 5 Wall Street analysts have set twelve-month price targets for Beam Therapeutics in the last year. company data provided by Morningstar and Zacks Investment Research. View which stocks have been most impacted by COVID-19. The JIM BEAM brand, founded in 1795 (United States), is part of our Top Popularity Web, has more than 96 sister brands and more than 1 027 competing brands.JIM BEAM 's notoriety arose from exemplary management which optimizes product quality and client satisfaction, which in turn generate financial performance, and therefore, stock performance. Beam shares closed up … What are … Beam Suntory Inc. has agreed to pay $19 million to resolve a criminal probe into bribes the maker of spirits allegedly paid to sell a line of its products in India, the U.S. Justice Department said. This price target is based on 5 analysts offering 12 month price targets for Beam Suntory in the last 3 months. Today's Strong And Under The Radar Stock Is Beam (BEAM) By Jamie Hodge. 2, 2020 at 7:58 a.m. Suntory's non-alcoholic beverage business is expanding successfully into international markets and was listed on the Tokyo Stock Exchange in 2013 as Suntory Beverage & Food Limited. Their average twelve-month price target is $33.60, suggesting a possible downside of 69.7%. June 29, 2020. The company is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Rapidly expanding Bay Area cannabis providers like Juva Life (OTC: JUVAF) are aiming to cash in. BEAM SUNTORY INC (NYSE:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BEAM SUNTORY INC | Nyse: | Nyse But legendary investor Whitney Tilson says the biggest part of this story is coming soon. Other companies that are similar to Beam Therapeutics include BioNTech, Novozymes A/S, CRISPR Therapeutics, argenx, Bio-Techne, QIAGEN, Repligen, Fate Therapeutics, Neurocrine Biosciences, Twist Bioscience, Adaptive Biotechnologies, Denali Therapeutics, Novavax, Acceleron Pharma and Iovance Biotherapeutics. Suntory Beverage & Food Ltd trades on the Tokyo Stock Exchange (2587). Suntory Buys Beam for $16 Billion, Gets Maker's Mark and Jim Beam. SUNTORY BEVERAGE & FOOD LIMITED (TYO:2587) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share SUNTORY BEVERAGE & FOOD LIMITED | Tokyo Stock Exchange: 2587 | Tokyo Stock Exchange whiskey . BEAM SUNTORY AUSTRIA GMBH, Kärntner Ring 5-7/7.Stock, 1010 Wien ALBERTA DISTILLERS, 1521 - 34th Avenue SE, Calgary, Alberta, T2G 1V9, Canada BEAM GLOBAL CANADA - MONTREAL, 550 Beaumont Avenue, Suite 402, Montreal, Quebec, Canada BEAM GLOBAL CANADA - TORONTO, 3280 Bloor Street West, Centre Tower 5th Floor, Suite 510, Toronto, Ontario, M8X 2X3,Canada BEAM GLOBAL CANADA - … Analyst Report: Fortune Brands Home & Security, Inc. Analyst Report: Fortune Brands Home & Sec In, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. In 2014 Suntory had acquired Beam Inc changing the company name to 'Beam Suntory'. The official website for Beam Therapeutics is www.beamtx.com.